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Abstract: Recent advances in high throughput biological methods allow researchers to generate enormous amounts of data 
from a single experiment. In order to extract meaningful conclusions from this tidal wave of data, it will be necessary to 
develop analytical methods of sufﬁ  cient power and utility. It is particularly important that biologists themselves be able to 
perform many of these analyses, such that their background knowledge of the experimental system under study can be used 
to interpret results and direct further inquiries. We have developed a web-based system, Magellan, which allows the upload, 
storage, and analysis of multivariate data and textual or numerical annotations. Data and annotations are treated as abstract 
entities, to maximize the different types of information the system can store and analyze. Annotations can be used in 
analyses/visualizations, as a means of subsetting data to reduce dimensionality, or as a means of projecting variables from 
one data type or data set to another. Analytical methods are deployed within Magellan such that new functionalities can be 
added in a straightforward fashion. Using Magellan, we performed an integrated analysis of genome-wide comparative 
genomic hybridization (CGH), mRNA expression, and clinical data from ovarian tumors. Analyses included the use of 
permutation-based methods to identify genes whose mRNA expression levels correlated with patient survival, a nearest 
neighbor classiﬁ  er to predict patient survival from CGH data, and curated annotations such as genomic position and derived 
annotations such as statistical computations to explore the quantitative relationship between CGH and mRNA expres-
sion data.
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Background
Recent advances in high-throughput genomic and proteomic analysis are generating enormous amounts 
of quantitative biological data. While there are distinct advantages to comprehensively quantifying 
biological variables such as mRNA expression level or genomic copy number across many genes and 
genomic loci, the scale of the data presents statistical challenges. The ratio of the number of measure-
ments to the number of samples can become very large, which can result in spurious statistical 
observations. Many groups have addressed this ‘multiple comparisons problem’. Resampling 
and permutation based approaches, for example, can help to establish meaningful significance 
cutoffs (Westfall and Young 1993; Tusher et al 2001; Segal et al 2003; Storey and Tibshirani 2003). 
Frequently, however, signals in such data sets are too subtle to yield statistics that pass rigorous sig-
niﬁ  cance cutoffs.
One particularly straightforward method to reduce dimensionality is to select only those variables 
that meet criteria that are orthogonal to the property being investigated. For the purposes of this discus-
sion, we deﬁ  ne a ‘data type’ as a category of qualitative or quantitative information gathered from a 
biological sample. In this study, the data types include mRNA expression level measurements, genomic 
copy number measurements, and patient survival data associated with ovarian tumors. A ‘variable’ is 
deﬁ  ned as a single measurement of a multivariate data type. Variables would include mRNA measure-
ments for individual genes or genomic copy number measurements for individual genomic regions.
Biological annotations can provide such a means of variable selection. By restricting a data set to 
only those variables whose annotations meet certain criteria, the dimensionality of the data set may 
be reduced such that multiple comparisons do not predominate. This concept, properly generalized, 11
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also supports integrated analysis across data types 
and across data sets. Given a series of tumor 
samples of known outcome, with experimental 
data comprising both DNA copy number and 
mRNA expression measurements, natural ques-
tions tend to span data types or require data anno-
tation. Does genomic copy number directly 
account for some of the variation in gene expres-
sion across samples? Are the genes that map to 
loci that are frequently found to be of aberrant 
copy number more likely to show an association 
with outcome than other genes? Are genes 
that have functional annotations for processes 
involved in cancer (for example, adhesion, apop-
tosis, invasion, ...) more likely to be associated 
with tumor aggressiveness?
Questions such as these, which combine aspects 
of biology with aspects of statistics, tend to be very 
difﬁ  cult for biological researchers themselves to 
answer during exploratory data analysis. Con-
versely, expert data analysts that have the skills 
required to answer such questions do not generally 
have the background to ask biologically motivated 
questions that might be stimulated by exploratory 
analysis. Since interpretation and exploration of 
data beneﬁ  t from the background knowledge of 
the biologist, we have implemented a web-based 
system called Magellan that supports integrated 
analysis of complex, heterogeneous data sets. 
Magellan’s target audience is not experts in 
data analysis, but experimentalists that wish to 
explore their own data using established analytical 
methods while incorporating biologically mean-
ingful annotations.
Here we present the Magellan system and its 
use in the analysis of combined comparative 
genomic hybridization (CGH), mRNA expression, 
and clinical data from 20 ovarian tumor samples 
(including 10 short survivors and 10 long survivors). 
Magellan supports univariate data analysis (with 
corrections for multiple comparisons), which 
identified one gene (spermidine/spermine 
N1-acetyltransferase) whose mRNA expression 
pattern correlated signiﬁ  cantly with patient sur-
vival. Analyzing CGH data, we observed no single 
genomic locus whose gain or loss correlated sig-
niﬁ  cantly with patient survival, but a simple clas-
sification approach correctly predicted patient 
survival in 85% of cases under cross-validation. 
By making use of biological annotations including 
genomic mapping locations and functional gene 
annotations, more complex observations could be 
quantiﬁ  ed: 1) DNA copy number and gene expres-
sion level are correlated genome-wide, on average; 
2) genomic loci that were enriched for genes whose 
variation in expression correlated with survival 
exhibited copy number variation that correlated 
better with survival than all loci; and 3) genes that 
mapped to genomic loci that were frequently 
altered in copy number showed variation that cor-
related better with survival than all genes.
Magellan is part of the National Cancer Bioin-
formatics Grid (CaBIG) Project (http://cabig.nci.
nih.gov/). Source code and documentation are 
available by email request. This system supports 
the use of open source analytical tools such that 
new methods of analysis can be rapidly prototyped 
and deployed. As part of the CaBIG project, 
instances of Magellan will be deployed at multiple 
institutions in support of cancer research across a 
wide community of experimentalists.
Methods and Data
The following describes the analytical and com-
putational methods in depth. The biological sam-
ples and experimental methods are presented 
brieﬂ  y, since the experimental methods have been 
described in detail elsewhere.
Experimental Samples 
and Biological Data
Twenty primary human ovarian tumor samples 
were analyzed in this study. Ten were tumors from 
patients that survived more than 7 years (long 
survivors), and 10 were from patients that survived 
less than 3 years (short survivors).
The tumors were analyzed by array CGH using 
experimental procedures previously described 
(Hodgson et al 2001; Snijders et al 2001). Brieﬂ  y, 
DNA samples from the tumors and from normal 
tissues were labeled with CY3 and CY5, respec-
tively, and hybridized to array comprised of rep-
licate BAC clones distributed at ~ megabase 
intervals along the genome. Hybridized arrays 
were counterstained with DAPI to facilitate array 
element segmentation. CY3/CY5/DAPI images 
were analyzed to determine CY3/CY5 intensity 
ratios for each element in the array using custom 
software (Jain et al 2002). Measurements of 
individual array elements were discarded if the 12
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within-spot Cy3:Cy5 pixel intensity correlation 
was 0.81, or if the number of pixels per array 
element was 25 (the average spot size was 
65 pixels) or if the CY3:CY5 ratio was 20% 
from the mean of 4 replicate measurements). This 
resulted in 2309 genomic loci after quality control 
and elimination of loci where more than 50% of 
samples had missing values. Note that missing 
values are typically caused by rejection of spots 
based on statistical concerns such as high replicate 
spot variance. Regions of the genome that have 
been deleted in the tumors should still be repre-
sented in the data set.
Expression data was collected as reported 
(Lancaster et al 2004), using the Affymetrix 
HuGeneFLGeneChip and Microarray Analysis 
Suite. This resulted in 7129 gene expression values 
for each sample.
Data Annotation
As described above, one of the challenges posed 
by modern experimental methods is that even with 
the largest practical sample sizes, frequently the 
number of measurements vastly exceeds the num-
ber of samples. Another challenge is heterogeneous 
data types, where multiple experimental methods 
are used on a common set of samples. Magellan 
makes use of annotation information, which can 
be used to reduce dimensionality within a single 
data type, but which also provides a rich means 
for working across data types (and even across 
data sets).
Annotations are generally deﬁ  ned as textual or 
numeric information that describes the variables 
of a data type. Annotations within Magellan can 
be either curated or derived. Curated annotations 
can consist of numerical information such as 
genomic mapping data for genes, textual informa-
tion derived from ontologies of gene function, and 
formal descriptions of regulatory networks (Ash-
burner et al 2000). Data and curated annotations 
are linked together through the use of ‘identiﬁ  ers’, 
which are user-deﬁ  ned names such as Genbank or 
RefSeq IDs.
Derived annotations are computed from the 
experimental measurements that comprise a data 
set. These annotations are the results of a compu-
tation performed on the data and are, therefore, 
derived from that data. Derived annotations are 
typically quantitative and are linked to data directly 
rather than through identiﬁ  ers. Direct linkage is 
required since individual identiﬁ  ers (representing 
one gene on a microarray, for example) can be 
represented multiple times in a data set, with 
different quantitative measurements in each phys-
ical instance yielding different annotation values. 
For the analyses performed here, we used derived 
annotations of correlation to patient outcome for 
gene expression and frequency of alteration of 
genomic copy number.
Magellan: A Web-Based System 
for Generalized Data Analysis
The primary aim of Magellan is to allow researchers 
to perform exploratory analyses of their data sets 
(hence the name Magellan). Biological data 
analysis has been the subject of intense research 
in many groups, and there are a number of systems 
available that are geared toward a similar user 
community. These range from single-use packages 
(such as clustering) to integrated packages for 
performing multiple types of analysis (such as 
univariate analyses and classiﬁ  cation for multiple 
data types). Examples of the former include 
methods such as SAM and PAM, which address 
permutation-corrected statistics and pattern clas-
sification, respectively (Tusher et al 2001; 
Tibshirani et al 2002), and Cluster and Tree-View 
(Eisen), which address clustering. Magellan 
differs from these in that it is a platform for 
offering multiple types of analysis. Examples of 
the latter include MeV (TIGR), caWorkBench 
(Columbia Genome Center), GeneCluster (Broad 
Institute), Gene-Sifter (VizX Labs LLC), and 
mAdb (NCI).
In terms of functionality, Magellan’s primary 
distinguishing characteristics are its generality and 
its use of biological annotation information as a 
means of constraining analyses to variable subsets. 
Magellan is general in two respects. First, the 
internal schema for storing information supports 
any type of data that can exist in a table (either 
numerical or textual). Second, Magellan does not 
impose complex format requirements on data, 
which is frequently a hurdle in making use of 
other systems, where local procedures for data 
preparation may be at variance with expectations 
and requirements for data formatting. Magellan 
currently allows users to deﬁ  ne the content and 13
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location of relevant information in a data ﬁ  le prior 
to storage of that information in the database. As 
part of the caBIG project, Magellan will be 
extended to accept several standard ﬁ  le formats.
Stored data and annotations are treated within 
Magellan as abstract entities, such that arbitrary, 
user deﬁ  ned types of information can be stored. 
This abstract approach to data and annotation rep-
resentation is similar to the EAV (Entity-Attribute-
Value) approach for modeling heterogeneous data, 
which allows a ﬂ  exible means of storing informa-
tion without limits on the number and type of 
attributes per entity (Nadkarni et al 1999). The 
database schema used to store data and annotations 
is graphically represented in Figure 1. Using this 
approach, experimental data may be any number 
of multidimensional vectors of information that 
belong to a sample. Likewise, annotations are 
abstractly deﬁ  ned as textual or quantitative infor-
mation that describes one or more variables of 
a given data type, such as genomic position or 
biological pathway information for a particular 
gene in an mRNA expression data set (Figure 2). 
Thus, an arbitrary number of user deﬁ  ned data and 
annotation types can be loaded and stored in the 
system, allowing very broad utility.
Magellan’s annotation representation was 
designed with ﬂ  exibility in mind, since much of 
the existing annotation information is informal 
and derived from varied sources. There do exist, 
however, many ‘standardized’ sources of annota-
tions that have been curated by third parties such 
as the Gene Ontology Consortium. In the current 
version of Magellan, these annotations may be 
used by direct upload of the information, as with 
any other source, standard or not. As a conve-
nience feature, direct retrieval of annotations from 
within caBIG enabled sources is part of the 
planned public release of Magellan. Users will be 
able to use Magellan to retrieve and utilize the stan-
dardized annotations curated as part of the caBIG 
project.
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Figure 1: Magellan architecture 
and database schema.
A.   System architecture, 
including the applications 
running on the various 
system components. An 
example web page is also 
shown.
B.   Database table structure. 
Tables used to store annota-
tion information are bordered 
with dashed lines.14
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Magellan’s architecture differs from most of the 
systems mentioned above in that it is a thin-client 
application, where the only requirement on a user 
is that they have a Web browser and an Internet 
connection. Magellan is based on an open archi-
tecture where integration of new analytical methods 
is straightforward. The intention is that a limited 
number of Magellan instances will be deployed in 
order to cover a large number of users, and new 
analytical methods will be interfaced as needed in 
order to support the user base. Access to all infor-
mation stored in Magellan is password protected, 
and access rights can be conferred upon selected 
individual users or made public, based on the pref-
erences of the owner of the data.
The web pages that provide the user interface 
to the Magellan system were developed using Java 
Server Pages technology. The use of Java allows 
developers to add functionality and deploy new 
algorithms to Magellan relatively easily, since 
much of the logic is contained in compiled Java 
classes that can be accessed via the documented 
API and modiﬁ  ed via inheritance. Magellan is 
designed to run on the Windows 2000 operating 
system, using the Apache Tomcat JSP servlet 
container, the Ant development tool, and Java 1.2. 
All information is currently stored using Oracle 
8.1 database software, although migration to an 
open source database application such as MySQL 
is possible in future releases. During development 
of Magellan, an attempt has been made to utilize 
standardized database interaction methods and 
procedures in order to facilitate such a port in the 
future. Analytical methods are currently deployed 
as compiled C executables or using the open source 
statistical package R, although any software that 
can be accessed via command line interfaces or 
scripts can potentially be interfaced to Magellan.
Additional details about the current version of 
Magellan (source code and documentation) are 
available by email request. An open-access version 
will be released as part of the caBIG deployment. 
A link to an instance of Magellan, pre-loaded with 
the data presented in this paper can be found at 
www.jainlab.org/publications.html. Note that 
while Magellan restricts user access to data owned 
by the speciﬁ  c user, network communications are 
not encrypted. Further, since the data model allows 
any type of data to be stored, it is left to the users 
to avoid storing sensitive data such as personally 
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Figure 2: Linkage of data 
to curated and derived 
annotation information. 
Variables of a data type 
(such as genes or genomic 
loci) are referenced by 
their ordinal position. The 
ordinal position can be 
directly linked to derived 
statistics (such as t-test 
against patient survival) or 
to named identiﬁ  ers (such 
as a Genbank IDs). Iden-
tiﬁ  ers are then used to link 
data to curated annota-
tions (such as genomic 
mapping information).15
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identiﬁ  able information about patients. All data 
reported here and present on the publicly available 
system has been de-identiﬁ  ed.
Results
As described above, CGH and mRNA expression 
data were obtained from twenty ovarian tumors, 
comprising ten long and ten short survivors. We 
used Magellan to explore the relationship between 
these two types of genomic data, and between 
the genomic data and accompanying clinical 
information. We performed standard analyses, 
which made use of a single data type at a time, with 
no use of annotation information. We also per-
formed multiple analyses that required annotation 
information, multiple data types, or both.
Single-Mode Analysis
Figure 3 shows the frequency of genomic copy 
number alteration for the twenty samples. Gains and 
losses previously shown to be common in ovarian 
tumors using chromosomal CGH (Shayesteh et al 
1999) are present. The resolution of array-based 
CGH further sharpens the structure of the abnor-
malities.
Correlation analysis was used to determine the 
relationship between genomic and clinical data, 
that is whether the behavior of any single gene or 
genomic locus signiﬁ  cantly correlated with patient 
survival class by t-test. The signiﬁ  cance threshold 
for the t-statistic was determined by a permutation-
based approach, as described previously (Jain 
et al 2001) using the 95
th percentile of the max 
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Figure 3: Graphical representation of the frequency of chromosomal gains/losses in 20 ovarian tumors. The ratio of genomic copy number 
in tumor vs. normal was log2 transformed and plotted against genomic position. Only those loci for which at least 20% of samples were 
aberrant at a log threshold of 0.25 were plotted16
Web-Based Analysis of Ovarian Tumor Data
Cancer Informatics 2006:2 
permutation distribution as a signiﬁ  cance cutoff. 
We found a signiﬁ  cant correlation between the 
expression of the spermidine/spermine 
N1-acetyltransferase (SSAT) gene and patient 
survival at p0.05. This is a conservative approach, 
since the null distribution is calculated from the 
maximum observed t-statistic from each round of 
permutation. The SSAT gene has been previously 
observed to be elevated in human prostate cancer, 
where it may have a role in maintaining polyamine 
homeostasis (Bettuzzi et al 2000). While the bio-
logical and clinical interpretation of the correlation 
between SSAT and patient survival in ovarian 
cancer is unclear at this point, the result demon-
strates use of Magellan to identify a correlation 
between gene expression and clinical outcome 
under a stringent test of signiﬁ  cance.
An identical analysis of the CGH data revealed 
no single locus with signiﬁ  cant association to 
clinical outcome. However, clustering samples 
using CGH loci whose copy number correlated 
with outcome showed a good segregation of sam-
ples based on class, suggesting possible success 
of outcome classiﬁ  cation by CGH data (Figure 4). 
K-nearest neighbors classiﬁ  cation with variable 
selection (Olshen and Jain 2002) yielded reasonable 
classiﬁ  cation performance under cross-validation. 
Variable selection was performed for each round 
of cross validation, using the t-statistic vs. outcome 
to select the top loci for each sample holdout. 
Using the Euclidean distance metric, we consis-
tently observed a better than random fraction of 
correctly classiﬁ  ed tumors using a number of dif-
ferent values for parameters such as the number 
of holdouts, number of loci, and number of 
neighbors (Table 1a, Table 1b). Due to the very 
small sample size, cross-validation estimates of 
classiﬁ  cation success were better for leave-one-out 
testing than for tests run with larger holdout sets. 
For the single-holdout cases, classiﬁ  cation perfor-
mance was 80 to 85% (Table 1a). Table 1b shows 
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Figure 4: Hierarchical clustering of samples based on loci whose DNA copy number correlated strongly with outcome. The t-statistic of copy 
number gain/loss for each genomic locus was used to select those loci that correlated strongly with outcome, and these restricted loci were 
used to cluster ovarian tumor samples. Survival – Green: long term survivors, Black: short term survivors. CGH Data – Green: gain of copy 
number, red: loss of copy number.
Table 1: Fraction of tumors correctly classiﬁ  ed using 
CGH data under cross validation. Tumors were classi-
ﬁ  ed using KNN with different numbers of holdouts, 
different numbers of genomic loci, and different values 
of K (the number of neighbors). The fraction of tumors 
that were correctly classiﬁ  ed for each set of parameters 
is reported. A. Fraction of tumors correctly classiﬁ  ed 
using 50 genomic loci but varying the number of 
holdouts and the value of K. B. Fraction of tumors 
correctly classiﬁ  ed using one holdout but varying the 
number of genomic loci and the value of K.
K
135 7
1 .85 .85 .80 .80
Holdouts 2 .75 .70 .65 .50
3 .80 .75 .70 .60
4 .60 .80 .70 .70
  5 .55 .70 .55 .50
K
135 7
5 .50 .45 .40 .65
Loci 10 .70 .50 .55 .60
25 .70 .80 .70 .60
50 .85 .85 .80 .80
  100 .70 .75 .65 .5517
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the effect of varying the number of selected loci 
under different values of K, using a single holdout. 
With a very small number of selected variables, 
performance was poor, but there was a broad peak 
of performance from 25 to 100 variables, centered 
at 50. Classiﬁ  ers based on mRNA expression data 
underperformed classiﬁ  ers based on CGH data, 
despite the converse result in the univariate 
analyses.
Given the very small number of samples, these 
results are encouraging to a degree, but require 
prospective validation on larger sample sets. The 
signal within the data is not overwhelmingly strong, 
and the single-mode analyses do not reveal compel-
ling results with respect to patient outcome.
Annotation Based Correlation 
Methods
The preceding analyses were performed indepen-
dently on the mRNA expression and CGH data 
sets. In order to relate the two data sets, we relied 
on annotations associated with the data. In par-
ticular, we used genomic mapping data to relate 
genes to ge-nomic loci (i.e. to identify corresponding 
variables in the two multivariate data types). We 
present two types of analysis: 1) where a statistical 
question relies directly upon annotation information, 
and 2) where a statistical computation is used as 
an annotation of genes in order to constrain a ques-
tion about genomic loci. The term ‘projection’ is 
used to describe the process of ﬁ  nding correspond-
ing variables between two data types by examining 
the relationship between the annotations associated 
with those variables.
Gene Dosage Effect: The presence of frequent 
alterations in copy number across the genome in 
this collection of ovarian tumors (Figure 3) sug-
gests that many genes could potentially be affected 
by gains or losses of genomic DNA. In order to 
determine the relationship between CGH and 
expression data (whether the sample-to-sample 
copy number of any genomic locus was correlated 
with the mRNA expression of any gene), we per-
formed a correlation analysis similar to that 
between genomic data and clinical data. Correla-
tion coefﬁ  cients were calculated for each pairwise 
combination of measurements for loci and genes, 
and signiﬁ  cance was determined by permutation 
analysis. No such correlations exceeded the 95th 
percentile cutoff of the permutation analysis, indi-
cating the inherent difﬁ  culty of ﬁ  nding relation-
ships between high-dimensional data types with a 
relatively small number of samples.
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We considered a more direct relationship 
between gene copy number and gene expression 
by incorporating biological annotations that used 
the genomic mapping of the BACs of the CGH 
array and the genes on the Affymetrix chip. The 
annotations were used to create bins of genes and 
loci based on common values. In this analysis, the 
genome was divided into 100 bins of equal length. 
Each bin of a two-dimensional matrix contained 
the genes (x-axis) and loci (y-axis) that mapped to 
those genomic regions indicated on the respective 
axes. The color of each bin was the average of all 
cross correlations of the DNA copy number for 
each genomic locus vs. the mRNA expression level 
of each gene within the bin.
Figure 5a shows a graphical depiction of the 
result computed and rendered from Magellan. An 
area of higher than background correlations is 
apparent along the diagonal of the graph, suggesting 
that expression of genes correlated with the ampli-
ﬁ  cation/deletion of loci that map nearby in the 
genome. The signiﬁ  cance of off diagonal correlation 
values is uncertain, but the correlation values for 
genes and loci that map to within 1Mb is signiﬁ  -
cantly different from the correlation values for 
genes and loci that are separated by at least 50Mb 
(p  0.001 by t-test). This is evidenced by the 
right-shift of the cumulative histogram of correlation 
values in the close-mapping case (Figure 5b).
Genome-wide, on average, ampliﬁ  cation of a 
genomic region tends to up-regulate the expres-
sion of genes in that region while genomic dele-
tion tends to down-regulate gene expression, a 
result that has also been observed in breast cancer 
(Pollack et al 2002). The result conﬁ  rms expecta-
tions, but there are two aspects of this analysis with 
respect to the Magellan platform that are important. 
First, the explicit use of annotation information 
(genomic mapping data) was required to make the 
correspondence between data types. Second, inte-
gration of the annotations with the data for the 
analysis was accomplished using a procedure eas-
ily accessible to a naïve user.
Gene Annotations: Gene Ontology annotations 
were available for most of the genes represented 
in the data set. These were loaded in Magellan as 
cu-rated annotations of the expression data type. 
As a demonstration of textual annotation use, we 
selected 394 genes with any of 13 cell cycle related 
gene annotations (features such as cell cycle, 
regulation of cell cycle, ...). We compared the 
distribution of gene correlations with survival from 
all genes versus those of the cell cycle, observing 
a rightward shift of the latter set. The shift was not 
quite signiﬁ  cant (p = 0.07 by Wilcoxon rank sum) 
and are presented here as an illustration, but the 
following results using derived annotations exhib-
ited signiﬁ  cant enrichment of extreme statistics.
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Figure 6: Projection of variables among 
two data types: from measurements of 
mRNA expression to DNA copy number 
by CGH. Cumulative distribution of 
t-statistics of CGH loci vs. survival for all 
loci (solid line) or loci that are within 1MB 
of one of the top 1% of genes that 
correlated with survival (dashed line). 
The distribution of statistics from 
subselected loci is signiﬁ  cantly shifted 
from unselected loci (p  0.05 by 
Wilcoxon rank-sum test).19
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Derived Annotations: In addition to curated 
annotations such as genomic position, data can be 
selected based upon quantitative annotations that 
are derived from the data itself (such as correlation 
with a clinical outcome) prior to analysis. This 
process can be useful in moving among data types 
within an experiment as well as moving between 
different experiments.
We computed the t-test for the mRNA expres-
sion data with respect to patient survival for each 
gene and selected the option within Magellan to 
store the values as a derived annotation for the 
expression data type. The expression data set was 
then sub-selected such that only those genes with 
statistic values in the top 1% were considered. 
Using the genomic mapping of the genes, those 
loci in the CGH data set that were in close physical 
proximity to the selected genes were selected. The 
cumulative histograms from the distribution of 
t-statistics for the 95 selected loci and the corre-
sponding distribution for all loci are shown in 
Figure 6. The cumulative histogram for the selected 
loci is shifted to the right of that of the unselected 
loci, indicating that genomic aberrations that are 
located near genes whose expression correlates 
with outcome exhibit copy number variation that 
is more strongly correlated with outcome (p  0.05 
by Wilcoxon rank-sum test).
In data sets with limited numbers of samples, 
such as the one presented here, it is often easier to 
observe signiﬁ  cant differences in distributions than 
in individual genes or loci. In the example just 
presented, we projected variables from the gene 
expression data type to the gene copy number data 
type, but we made use of outcome information in 
the process. Since we have shown a direct relation-
ship between measurements of genome copy 
number and expression, the effect may be a simple 
manifestation of the same process.
However, since genome copy number has an 
expected normal value (a relative log ratio of 
0 compared with normal), we can identify genomic 
loci that are involved with the disease process 
without reference to outcome. We identified 
genomic loci that met progressively more stringent 
tests of frequency of aberration and considered the 
behavior of the genes that mapped close by with 
respect to patient outcome. Figure 7 shows cumu-
lative histograms of the t-statistics of gene expres-
sion for multiple subsets of genes. The leftmost 
distribution was from all genes. Each succeeding 
distribution was computed from progressively 
more stringent criteria. The shift in distributions 
is monotonic, and the difference between the 
distributions for all genes compared with those 
genes that map to loci that are most frequently 
altered is signiﬁ  cant (p  0.05 by Wil-coxon 
rank-sum test).
Conclusions
We have developed an analytical system capable of 
performing complex analyses on high-dimensional 
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Figure 7: Projection of variables among two 
data types: from measurements of DNA copy 
number by CGH to mRNA expression. Cumu-
lative distributions of t-statistics of mRNA 
expression vs. survival for all genes (solid 
black line) or genes that are within 1MB of 
CGH loci whose log2 deviation from normal 
is at least 0.5 at a frequency of at least 20% 
(dashed green line), 25% (dashed blue line), 
or 30% (dashed red line) of samples. The 
difference between the distributions for all 
genes compared with those genes that 
map to loci that are altered in 30% or more 
samples is signiﬁ  cant (p  0.05 by Wilcoxon 
rank-sum test).20
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data and annotations. We demonstrated Magellan’s 
application on a speciﬁ  c genomic data set contain-
ing CGH, mRNA gene expression, and clinical 
outcome data from ovarian tumors. Using this 
system, we were able to ﬁ  nd a signiﬁ  cant correla-
tion between expression of the SSAT gene and 
patient survival, and we are able to build a CGH 
based classiﬁ  er that correctly predicts survival 85% 
of the time in cross validation. It is important to 
note that these results are derived from a small data 
set comprising a selected group of patients, and 
any conclusions need to be reproduced on larger 
data sets.
By making use of curated annotations, stronger 
conclusions about the relationship between genome 
copy number and gene expression could be made. 
In particular, on average, genome-wide, there is a 
signiﬁ  cant component of gene expression variation 
that is explained by changes in genomic copy 
number. Using combinations of curated and 
derived annotations, we showed enrichment for 
relationship to survival in moving from gene 
expression data to genome copy number data and 
vice versa.
The analyses are possible in the context of a 
thin-client architecture that is accessible to the 
community of experimental biologists. End users 
access Magellan through a web browser, providing 
a very low barrier for use of the system; there is 
no software to install on the client-side. Magellan 
includes web-based documentation to assist users 
in the uploading and analysis of data and annota-
tions. The system architecture is built around 
central web, database, and application servers that 
store all data and annotations in a relational data-
base. Because data and annotations are represented 
abstractly, users are able to perform a limitless 
variety of annotation-based selections on virtually 
any type of data prior to analysis.
Magellan is part of the National Cancer 
Bioinformatics Grid (CaBIG) Project. Currently, 
the upload, storage, and analysis functions 
described in this manuscript are functionally 
mature. Within the next year, connectivity to the 
data and annotation stores at the NCI will be 
achieved. In addition, several open source statisti-
cal tools will be incorporated into Magellan, par-
ticularly the R based tools of the Bioconductor 
project such as the aCGH package for the analysis 
of CGH data. The Magellan source code and 
documentation are available by email request. 
A link to an instance of Magellan preloaded with 
the data described in this paper is also accessible 
online at www.jainlab.org/publications.html. As 
part of the CaBIG project, instances of Magellan 
will be deployed at multiple institutions in support 
of cancer research across a wide community of 
experimentalists.
Magellan’s source code and documentation will 
become publicly available within the caBIG web-
based CVS system. The ﬁ  rst public release, sched-
uled for early 2006, will include the functions 
described here and will also include improvements 
in interface functionality, online documentation, 
and standardized annotation retrieval. These 
aspects are being developed in collaboration with 
formal adopters in the caBIG community and rep-
resent an ongoing collaboration among developers 
and users of Magellan.
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